ATAD2 |
ATAD2, L16, PRO2000: ATPase family AAA domain-containing protein 2 |
POLE3 |
POLE3, CHRAC17: DNA polymerase epsilon subunit 3 |
2.672 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
CAV1 |
CAV1, CAV: Caveolin-1 |
2.665 |
Evidence |
|
STAT5B |
STAT5B: Signal transducer and activator of transcription 5B |
CAV1 |
CAV1, CAV: Caveolin-1 |
2.665 |
Evidence |
|
FKBP4 |
FKBP4: FK506-binding protein 4 |
RBBP4 |
RBBP4, RBAP48: Histone-binding protein RBBP4 |
2.662 |
Evidence |
|
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
CSK |
CSK: Tyrosine-protein kinase CSK |
2.655 |
Evidence |
|
SPINK1 |
SPINK1, PSTI: Pancreatic secretory trypsin inhibitor precursor |
NOTCH2 |
NOTCH2: Neurogenic locus notch homolog protein 2 precursor |
2.655 |
Evidence |
|
NCAM1 |
NCAM1, NCAM: Neural cell adhesion molecule 1, 140 kDa isoform precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
2.655 |
Evidence |
|
LYPD3 |
LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor |
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
2.655 |
Evidence |
|
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
SYK |
SYK: Tyrosine-protein kinase SYK |
2.655 |
Evidence |
|
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
CTTN |
CTTN, EMS1: Src substrate cortactin |
2.655 |
Evidence |
|
NCK1 |
NCK1, NCK: Cytoplasmic protein NCK1 |
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
2.655 |
Evidence |
|
LYPD3 |
LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor |
VAV1 |
VAV1, VAV: Proto-oncogene vav |
2.655 |
Evidence |
|
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.655 |
Evidence |
|
CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
PARVA |
PARVA, MXRA2: Alpha-parvin |
2.655 |
Evidence |
|
KEL |
KEL: Kell blood group glycoprotein |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
2.655 |
Evidence |
|
LYPD3 |
LYPD3, C4.4A, UNQ491/PRO1007: Ly6/PLAUR domain-containing protein 3 precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.655 |
Evidence |
|
AGTR1 |
AGTR1, AGTR1A, AGTR1B, AT2R1, AT2R1B: Type-1 angiotensin II receptor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.655 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
ETV1 |
ETV1, ER81: ETS translocation variant 1 |
2.655 |
Evidence |
|
GLRA1 |
IPI00011565 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
2.655 |
Evidence |
|
F8 |
F8, F8C: Coagulation factor VIII precursor |
CD3G |
CD3G, T3G: T-cell surface glycoprotein CD3 gamma chain precursor |
2.655 |
Evidence |
|
F5 |
F5: Coagulation factor V precursor |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
2.655 |
Evidence |
|
ACTN4 |
ACTN4: Alpha-actinin-4 |
EIF3S9 |
EIF3S9: Eukaryotic translation initiation factor 3 subunit 9 |
2.652 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
2.65 |
Evidence |
|
NPPC |
NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
2.65 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
IL12B |
IL12B, NKSF2: Interleukin-12 subunit beta precursor |
2.65 |
Evidence |
|